サマリー

市場の分析と洞察。生物医薬品の添加剤の世界市場
COVID-19の大流行により、バイオ医薬品添加剤の世界市場規模は2022年に百万米ドル相当と推定され、レビュー期間中にCAGR %で2028年までに百万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、2021年にバイオ医薬品賦形剤世界市場の％を占めたトリグリセリドは、2028年までに百万米ドルの価値を持ち、COVID-19後の期間に修正された％のCAGRで成長すると予測されます。一方、経口製剤セグメントは、この予測期間を通して％CAGRに変更されています。

中国の生物医薬品添加剤の市場規模は2021年に100万米ドル、米国と欧州の生物医薬品添加剤はそれぞれ100万米ドル、100万米ドルとされています。米国の割合は2021年に％、中国と欧州はそれぞれ％と％であり、中国の割合は2028年に％に達すると予測され、分析期間を通じてCAGRは％であることを追跡しています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％である。ヨーロッパの生物医薬品添加剤の展望については、ドイツは2028年までに100万米ドルに達すると予測され、予測期間を通じてCAGR %を推移します。

バイオ医薬品添加剤の世界的な主要メーカーは、Dow、BASF、ER-KANG、JRS Pharma、Lubrizol、Ashland、Roquette、信越、Evonikなどです。2021年、世界の上位5社は売上高で約 %のシェアを占めています。
生産面では、2017年から2022年まで、2028年までの予測で、メーカー別、地域別（地域レベル、国レベル）のバイオ医薬品添加剤の容量、生産量、成長率、市場シェアを調査しています。
販売面では、地域別（地域レベル、国レベル）、企業別、タイプ別、用途別のバイオ医薬品用賦形剤の売上高に焦点を当て、2017年から2022年まで、2028年までの予測を掲載しています。

世界のバイオ医薬品用添加剤の範囲とセグメント
バイオ医薬品添加剤市場は、タイプ別、用途別に分類されています。世界のバイオ医薬品賦形剤市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができます。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の生産能力、収益、予測に焦点を当てます。

種類別セグメント
トリグリセリド
マンニトール
ソルビトール
スクロース
デキストロース
澱粉
その他
用途別セグメント
経口製剤
局所用製剤
非経口製剤
その他

会社別
ダウ
BASF
ER-KANG
JRSファーマ
ルーブリゾール
アシュランド
ロケット
信越
エボニック
アビテック株式会社
シグネットケミカル株式会社
シガチ工業
メーグル社

地域別生産量
北米
欧州
中国
日本
地域別消費量
北アメリカ
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE

ページTOPに戻る

目次

1 Study Coverage
1.1 Biopharmaceuticals Excipients Product Introduction
1.2 Market by Type
1.2.1 Global Biopharmaceuticals Excipients Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Triglycerides
1.2.3 Mannitol
1.2.4 Sorbitol
1.2.5 Sucrose
1.2.6 Dextrose
1.2.7 Starch
1.2.8 Others
1.3 Market by Application
1.3.1 Global Biopharmaceuticals Excipients Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Oral Formulations
1.3.3 Topical Formulations
1.3.4 Parenteral Formulations
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Biopharmaceuticals Excipients Production
2.1 Global Biopharmaceuticals Excipients Production Capacity (2017-2028)
2.2 Global Biopharmaceuticals Excipients Production by Region: 2017 VS 2021 VS 2028
2.3 Global Biopharmaceuticals Excipients Production by Region
2.3.1 Global Biopharmaceuticals Excipients Historic Production by Region (2017-2022)
2.3.2 Global Biopharmaceuticals Excipients Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Biopharmaceuticals Excipients Sales in Volume & Value Estimates and Forecasts
3.1 Global Biopharmaceuticals Excipients Sales Estimates and Forecasts 2017-2028
3.2 Global Biopharmaceuticals Excipients Revenue Estimates and Forecasts 2017-2028
3.3 Global Biopharmaceuticals Excipients Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Biopharmaceuticals Excipients Sales by Region
3.4.1 Global Biopharmaceuticals Excipients Sales by Region (2017-2022)
3.4.2 Global Sales Biopharmaceuticals Excipients by Region (2023-2028)
3.5 Global Biopharmaceuticals Excipients Revenue by Region
3.5.1 Global Biopharmaceuticals Excipients Revenue by Region (2017-2022)
3.5.2 Global Biopharmaceuticals Excipients Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Biopharmaceuticals Excipients Production Capacity by Manufacturers
4.2 Global Biopharmaceuticals Excipients Sales by Manufacturers
4.2.1 Global Biopharmaceuticals Excipients Sales by Manufacturers (2017-2022)
4.2.2 Global Biopharmaceuticals Excipients Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Biopharmaceuticals Excipients in 2021
4.3 Global Biopharmaceuticals Excipients Revenue by Manufacturers
4.3.1 Global Biopharmaceuticals Excipients Revenue by Manufacturers (2017-2022)
4.3.2 Global Biopharmaceuticals Excipients Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Biopharmaceuticals Excipients Revenue in 2021
4.4 Global Biopharmaceuticals Excipients Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Biopharmaceuticals Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Biopharmaceuticals Excipients Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Biopharmaceuticals Excipients Sales by Type
5.1.1 Global Biopharmaceuticals Excipients Historical Sales by Type (2017-2022)
5.1.2 Global Biopharmaceuticals Excipients Forecasted Sales by Type (2023-2028)
5.1.3 Global Biopharmaceuticals Excipients Sales Market Share by Type (2017-2028)
5.2 Global Biopharmaceuticals Excipients Revenue by Type
5.2.1 Global Biopharmaceuticals Excipients Historical Revenue by Type (2017-2022)
5.2.2 Global Biopharmaceuticals Excipients Forecasted Revenue by Type (2023-2028)
5.2.3 Global Biopharmaceuticals Excipients Revenue Market Share by Type (2017-2028)
5.3 Global Biopharmaceuticals Excipients Price by Type
5.3.1 Global Biopharmaceuticals Excipients Price by Type (2017-2022)
5.3.2 Global Biopharmaceuticals Excipients Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Biopharmaceuticals Excipients Sales by Application
6.1.1 Global Biopharmaceuticals Excipients Historical Sales by Application (2017-2022)
6.1.2 Global Biopharmaceuticals Excipients Forecasted Sales by Application (2023-2028)
6.1.3 Global Biopharmaceuticals Excipients Sales Market Share by Application (2017-2028)
6.2 Global Biopharmaceuticals Excipients Revenue by Application
6.2.1 Global Biopharmaceuticals Excipients Historical Revenue by Application (2017-2022)
6.2.2 Global Biopharmaceuticals Excipients Forecasted Revenue by Application (2023-2028)
6.2.3 Global Biopharmaceuticals Excipients Revenue Market Share by Application (2017-2028)
6.3 Global Biopharmaceuticals Excipients Price by Application
6.3.1 Global Biopharmaceuticals Excipients Price by Application (2017-2022)
6.3.2 Global Biopharmaceuticals Excipients Price Forecast by Application (2023-2028)
7 North America
7.1 North America Biopharmaceuticals Excipients Market Size by Type
7.1.1 North America Biopharmaceuticals Excipients Sales by Type (2017-2028)
7.1.2 North America Biopharmaceuticals Excipients Revenue by Type (2017-2028)
7.2 North America Biopharmaceuticals Excipients Market Size by Application
7.2.1 North America Biopharmaceuticals Excipients Sales by Application (2017-2028)
7.2.2 North America Biopharmaceuticals Excipients Revenue by Application (2017-2028)
7.3 North America Biopharmaceuticals Excipients Sales by Country
7.3.1 North America Biopharmaceuticals Excipients Sales by Country (2017-2028)
7.3.2 North America Biopharmaceuticals Excipients Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Biopharmaceuticals Excipients Market Size by Type
8.1.1 Europe Biopharmaceuticals Excipients Sales by Type (2017-2028)
8.1.2 Europe Biopharmaceuticals Excipients Revenue by Type (2017-2028)
8.2 Europe Biopharmaceuticals Excipients Market Size by Application
8.2.1 Europe Biopharmaceuticals Excipients Sales by Application (2017-2028)
8.2.2 Europe Biopharmaceuticals Excipients Revenue by Application (2017-2028)
8.3 Europe Biopharmaceuticals Excipients Sales by Country
8.3.1 Europe Biopharmaceuticals Excipients Sales by Country (2017-2028)
8.3.2 Europe Biopharmaceuticals Excipients Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Biopharmaceuticals Excipients Market Size by Type
9.1.1 Asia Pacific Biopharmaceuticals Excipients Sales by Type (2017-2028)
9.1.2 Asia Pacific Biopharmaceuticals Excipients Revenue by Type (2017-2028)
9.2 Asia Pacific Biopharmaceuticals Excipients Market Size by Application
9.2.1 Asia Pacific Biopharmaceuticals Excipients Sales by Application (2017-2028)
9.2.2 Asia Pacific Biopharmaceuticals Excipients Revenue by Application (2017-2028)
9.3 Asia Pacific Biopharmaceuticals Excipients Sales by Region
9.3.1 Asia Pacific Biopharmaceuticals Excipients Sales by Region (2017-2028)
9.3.2 Asia Pacific Biopharmaceuticals Excipients Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Biopharmaceuticals Excipients Market Size by Type
10.1.1 Latin America Biopharmaceuticals Excipients Sales by Type (2017-2028)
10.1.2 Latin America Biopharmaceuticals Excipients Revenue by Type (2017-2028)
10.2 Latin America Biopharmaceuticals Excipients Market Size by Application
10.2.1 Latin America Biopharmaceuticals Excipients Sales by Application (2017-2028)
10.2.2 Latin America Biopharmaceuticals Excipients Revenue by Application (2017-2028)
10.3 Latin America Biopharmaceuticals Excipients Sales by Country
10.3.1 Latin America Biopharmaceuticals Excipients Sales by Country (2017-2028)
10.3.2 Latin America Biopharmaceuticals Excipients Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Biopharmaceuticals Excipients Market Size by Type
11.1.1 Middle East and Africa Biopharmaceuticals Excipients Sales by Type (2017-2028)
11.1.2 Middle East and Africa Biopharmaceuticals Excipients Revenue by Type (2017-2028)
11.2 Middle East and Africa Biopharmaceuticals Excipients Market Size by Application
11.2.1 Middle East and Africa Biopharmaceuticals Excipients Sales by Application (2017-2028)
11.2.2 Middle East and Africa Biopharmaceuticals Excipients Revenue by Application (2017-2028)
11.3 Middle East and Africa Biopharmaceuticals Excipients Sales by Country
11.3.1 Middle East and Africa Biopharmaceuticals Excipients Sales by Country (2017-2028)
11.3.2 Middle East and Africa Biopharmaceuticals Excipients Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Dow
12.1.1 Dow Corporation Information
12.1.2 Dow Overview
12.1.3 Dow Biopharmaceuticals Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Dow Biopharmaceuticals Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Dow Recent Developments
12.2 BASF
12.2.1 BASF Corporation Information
12.2.2 BASF Overview
12.2.3 BASF Biopharmaceuticals Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 BASF Biopharmaceuticals Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 BASF Recent Developments
12.3 ER-KANG
12.3.1 ER-KANG Corporation Information
12.3.2 ER-KANG Overview
12.3.3 ER-KANG Biopharmaceuticals Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 ER-KANG Biopharmaceuticals Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 ER-KANG Recent Developments
12.4 JRS Pharma
12.4.1 JRS Pharma Corporation Information
12.4.2 JRS Pharma Overview
12.4.3 JRS Pharma Biopharmaceuticals Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 JRS Pharma Biopharmaceuticals Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 JRS Pharma Recent Developments
12.5 Lubrizol
12.5.1 Lubrizol Corporation Information
12.5.2 Lubrizol Overview
12.5.3 Lubrizol Biopharmaceuticals Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Lubrizol Biopharmaceuticals Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Lubrizol Recent Developments
12.6 Ashland
12.6.1 Ashland Corporation Information
12.6.2 Ashland Overview
12.6.3 Ashland Biopharmaceuticals Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Ashland Biopharmaceuticals Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Ashland Recent Developments
12.7 Roquette
12.7.1 Roquette Corporation Information
12.7.2 Roquette Overview
12.7.3 Roquette Biopharmaceuticals Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Roquette Biopharmaceuticals Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Roquette Recent Developments
12.8 Shin-Etsu
12.8.1 Shin-Etsu Corporation Information
12.8.2 Shin-Etsu Overview
12.8.3 Shin-Etsu Biopharmaceuticals Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Shin-Etsu Biopharmaceuticals Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Shin-Etsu Recent Developments
12.9 Evonik
12.9.1 Evonik Corporation Information
12.9.2 Evonik Overview
12.9.3 Evonik Biopharmaceuticals Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Evonik Biopharmaceuticals Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Evonik Recent Developments
12.10 ABITEC Corp
12.10.1 ABITEC Corp Corporation Information
12.10.2 ABITEC Corp Overview
12.10.3 ABITEC Corp Biopharmaceuticals Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 ABITEC Corp Biopharmaceuticals Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 ABITEC Corp Recent Developments
12.11 Signet Chemical Corporation
12.11.1 Signet Chemical Corporation Corporation Information
12.11.2 Signet Chemical Corporation Overview
12.11.3 Signet Chemical Corporation Biopharmaceuticals Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Signet Chemical Corporation Biopharmaceuticals Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Signet Chemical Corporation Recent Developments
12.12 Sigachi Industries
12.12.1 Sigachi Industries Corporation Information
12.12.2 Sigachi Industries Overview
12.12.3 Sigachi Industries Biopharmaceuticals Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Sigachi Industries Biopharmaceuticals Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Sigachi Industries Recent Developments
12.13 MEGGLE AG
12.13.1 MEGGLE AG Corporation Information
12.13.2 MEGGLE AG Overview
12.13.3 MEGGLE AG Biopharmaceuticals Excipients Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 MEGGLE AG Biopharmaceuticals Excipients Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 MEGGLE AG Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Biopharmaceuticals Excipients Industry Chain Analysis
13.2 Biopharmaceuticals Excipients Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Biopharmaceuticals Excipients Production Mode & Process
13.4 Biopharmaceuticals Excipients Sales and Marketing
13.4.1 Biopharmaceuticals Excipients Sales Channels
13.4.2 Biopharmaceuticals Excipients Distributors
13.5 Biopharmaceuticals Excipients Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Biopharmaceuticals Excipients Industry Trends
14.2 Biopharmaceuticals Excipients Market Drivers
14.3 Biopharmaceuticals Excipients Market Challenges
14.4 Biopharmaceuticals Excipients Market Restraints
15 Key Finding in The Global Biopharmaceuticals Excipients Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer